Ali Ramazan Benli

Dr. Ali Ramazan Benli


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Journal of Clinical Medicine Research
Verified
Journal Article
Open access
PDF file
ABAli Ramazan Benli
Ali Ramazan Benli
NBNeriman Cetin Benli
Neriman Cetin Benli
AUAbdullah Taner Usta
Abdullah Taner Usta
TATolga Atakul
Tolga Atakul
MKMustafa Koroglu
Mustafa Koroglu
Effect of Maternal Age on Pregnancy Outcome and Cesarean Delivery Rate

1 February 2017 in Tobacco Induced Diseases
Verified
Journal Article
Open access
ABAli Ramazan Benli
Ali Ramazan Benli
SESelman Erturhan
Selman Erturhan
MOMuhammet Ali Oruc
Muhammet Ali Oruc
PKPinar Kalpakci
Pinar Kalpakci
DSDidem Sunay
Didem Sunay
YDYeltekin Demirel
Yeltekin Demirel
Background: Within the context of the support program for smoking cessation, initiated by the Turkish Ministry of Health in 2011, those who present at ‘smoking cessation’ centres and are found to be suitable for pharmacological treatment are given varenicline and bupropion free of charge....

1 February 2020 in Complementary Therapies in Clinical Practice
Verified
Journal Article
Closed access
SESuleyman Ersoy
Suleyman Ersoy
ABAli Ramazan Benli
Ali Ramazan Benli

29 December 2017 in Medical Science Monitor
Verified
Journal Article
Open access
PDF file
ABAli Ramazan Benli
Ali Ramazan Benli
DSDidem Sunay
Didem Sunay
BACKGROUND:The aim of this study was to evaluate the effect of blood-letting with wet cupping therapy (WCT) in migraine treatment and to determine whether there was any difference according to the phase of the moon when the treatment was applied. MAT...

3 January 2020 in The European Research Journal
Verified
Journal Article
Open access
AYAbdulkerim Yıldız
Abdulkerim Yıldız
AYAli Yiğt
Ali Yiğt
ABAli Ramazan Benli
Ali Ramazan Benli
Objectives: Comorbidities represent a risk factor for adverse events in several critical illnesses. The aim of this study was to identify the relationship between the Charlson Comorbidity Index (CCI) with mortality and length of stay (LOS) in critically ill elderly patients.Methods: A retrospective analysis was made of patients admitted to our tertiary adult intensive care unit (ICU) between January 2015 and January 2016. The impact of comorbidity was evaluated with the CCI. Other required data were retrieved from the patients' follow-up records.Results: The study included a total of 251 patients. The mean age was 78.79 ± 6.70 years. The total mortality rate was 41.0%. The most common cause for admission was sepsis and acute respiratory failure (18.3% vs 18.3%). The median APACHE II score was significantly higher in non-survivors than survivors (31.0 [13.0-47.0] vs 21.0 [9.0-40.0]; p < 0.01). The median CCI was 2.0 (0.0-7.0) for survivors and 3.0 (1.0-10.0) for non-survivors. The CCI of non-survivors was significantly higher than that of survivors (p = 0.005). Patients with CCI > 3 had higher mortality than those with CCI ≤ 3 (p < 0.05). The odds ratio of the APACHE II score for mortality was 1.214 (95% CI: 1.154-1.276), and for CCI it was 1.320 (95% CI: 1.088-1.602). There was a significant positive correlation between CCI and LOS (r=0.147; p = 0.020). Conclusions: CCI is strongly associated with both mortality and LOS. It can be used as a prognostic marker for elderly patients in critical care.

15 April 2017 in ARCHIVES OF CLINICAL AND EXPERIMENTAL MEDICINE
Verified
Journal Article
Open access
HAHabibullah Aktaş
Habibullah Aktaş
GEGökşen Ertuğrul
Gökşen Ertuğrul
ABAli Ramazan Benli
Ali Ramazan Benli
Tr en Amaç: Bu çalışmada, genital siğil tanısı almış hastalarda cinsel yolla bulaşan diğer hastalıklara ait serolojik test sonuçlarının değerlendirilmesi hedeflenmiştir. Yöntemler: Şubat 2015 ile Temmuz 2016 arasında dermatoloji polikliniğinde genital siğil tanısı alan 74' ü erkek 35' i kadın 109 hastanın dosya kayıtları taranarak, cinsel yolla bulaşan diğer hastalıklara ait veriler elde edildi. Sonuçlar demografik olarak değerlendirildi. Bulgular: Sonuçları elde edilen 109 hastanın 74’ü erkek 35’i bayandı. Yaş ortalaması 33,7 yıl bulundu. Hiçbir hastada HIV ve VDRL testi pozitif bulunmazken, bir erkek hastada HBsAg, bir kadın hastada da anti-HCV testi pozitif saptandı. 28 hastada anti-HBs pozitif idi. Kadın hastaların sadece % 17,6 sı 40 yaş üzerinde iken, erkek hastalarda bu oran %36,4 ile daha yüksek bulundu. Sonuç: Genital siğillerin cinsel yolla bulaşan diğer hastalıkların görülme sıklığını da artırması beklenirken, bulunan oranlar genital siğilin hepatit B, hepatit C, edinsel immün yetmezlik sendromu, sifiliz gibi diğer hastalıkların görülme sıklığını değiştirmediğini gösterdi. Uzun izlemli, daha geniş sayıda taramalar daha sağlıklı çıkarımlar sağlayacaktır. Aim: In this study, we aimed the possible coexistence of other sexullay transmitted diseases with condyloma acuminata patients. Methods: The files of 109 condyloma acuminata patients admitted between February 2015 and July 2016 were searched retrospectively. Their serological test results were noted according to their demographic properties. Results: Of 109 patients whose results obtained, 74 were male and 35 were female patients. Average age of the patients was 33.7 years. There was no positive case of VDRL and anti-HIV, however, HBsAg positivity in a male patient and anti-HCV positivity in a female patient were detected. A total of 28 patients was found to have anti-HBs positivity. While only 17.6% of the female patients were over 40 years old, that number was significantly higher as 36.4% in male patients with condyloma acuminata. Conclusion: Although there is a prediction that condyloma acuminata patients have more incidence of other sexually transmitted diseases, this small retrospective study shows no more coexistence between condyloma acuminata and other sexually transmitted diseases. However, further studies with high number of patients and long-term follow up will provide better conclusions.